Value
8.1/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 7.4 |
| P/S | 9.2 |
| EV/EBITDA | 6.2 |
| Fwd P/E | 7.9 |
| PEG | 10.0 |
| Analyst target | 7.5 |
- ▸Forward P/E: 15.3x
- ▸PEG: 0.50
- ▸Attractively valued
EHC · Why this verdict
Why Encompass Health (EHC) is rated HOLD
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictHOLD
Overall score6.2/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Encompass Health has delivered four consecutive earnings beats and offers 23 percent upside to the analyst target with a strongly favorable risk/reward geometry, but a confirmed price downtrend and elevated put/call activity signal the market has not yet recognized the opportunity — patience is warranted until the technical picture stabilizes.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The company has beaten earnings estimates in each of the past four quarters, with an average positive surprise of approximately 9.6 percent — a track record that reflects consistent execution against guidance and suggests management is deliberately setting achievable targets. Earnings | Earnings beats continue in each of the next two reported quarters with positive surprises averaging above 5 percent, reinforcing the delivery record and supporting analyst target upgrades. | →Stable |
| CounterA perfect beat streak can reflect conservative guidance discipline that cannot be sustained indefinitely; if the macro or reimbursement environment shifts, the streak breaks and the market re-rates the shares sharply lower. | ||
The shares sit 23 percent below the analyst consensus target at $122.23, and the risk/reward geometry clears the asymmetry bar required for a high-conviction setup — offering a materially favorable ratio of potential gain to potential loss at the current price of $99.36. Price targets | Over 12 months, the share price closes the 23-percent gap to the analyst target as earnings deliver and the technical picture improves, capturing the reward side of the asymmetric setup. | →Stable |
| CounterA favorable asymmetry ratio assumes the downside target holds; if the downtrend deepens and the stock breaks through near-term support, the downside estimate will be revised lower and the apparent risk/reward advantage will narrow. | ||
The share price is below its 200-day moving average, the 50-day has crossed below the 200-day, and the moving-average slope is declining at 1.4 percent per 30 days — a confirmed downtrend configuration that creates meaningful entry-timing risk regardless of the fundamental picture. Momentum breakdown | The downtrend reverses over the next two quarters as the moving-average slope flattens and on-balance volume transitions to accumulation, reducing the technical entry risk. | →Stable |
| CounterThe large 23-percent gap to the analyst target and the exceptional asymmetry ratio suggest the downtrend may already be overdone relative to fundamentals, in which case the technical setup resolves faster than the moving-average signals currently imply. | ||
The put-to-call ratio stands at 2.33, a level well above normal that indicates the options market is heavily skewed toward downside protection — a signal that institutional participants are actively hedging against further price declines rather than positioning for a recovery. Risk breakdown | The put/call ratio falls below 1.0 over the next two quarters as the downtrend reverses and the hedging overhang is unwound, removing a technical headwind to share-price recovery. | →Stable |
| CounterElevated put/call ratios can represent contrarian bullish signals when sentiment reaches an extreme; the concentration of put activity may mark a sentiment trough from which the shares are close to recovering, rather than a sign of sustained institutional conviction in the downside. | ||
The company has beaten earnings estimates in each of the past four quarters, with an average positive surprise of approximately 9.6 percent — a track record that reflects consistent execution against guidance and suggests management is deliberately setting achievable targets.
→StableEarnings
- Expectation
- Earnings beats continue in each of the next two reported quarters with positive surprises averaging above 5 percent, reinforcing the delivery record and supporting analyst target upgrades.
CounterA perfect beat streak can reflect conservative guidance discipline that cannot be sustained indefinitely; if the macro or reimbursement environment shifts, the streak breaks and the market re-rates the shares sharply lower.
The shares sit 23 percent below the analyst consensus target at $122.23, and the risk/reward geometry clears the asymmetry bar required for a high-conviction setup — offering a materially favorable ratio of potential gain to potential loss at the current price of $99.36.
→StablePrice targets
- Expectation
- Over 12 months, the share price closes the 23-percent gap to the analyst target as earnings deliver and the technical picture improves, capturing the reward side of the asymmetric setup.
CounterA favorable asymmetry ratio assumes the downside target holds; if the downtrend deepens and the stock breaks through near-term support, the downside estimate will be revised lower and the apparent risk/reward advantage will narrow.
The share price is below its 200-day moving average, the 50-day has crossed below the 200-day, and the moving-average slope is declining at 1.4 percent per 30 days — a confirmed downtrend configuration that creates meaningful entry-timing risk regardless of the fundamental picture.
→StableMomentum breakdown
- Expectation
- The downtrend reverses over the next two quarters as the moving-average slope flattens and on-balance volume transitions to accumulation, reducing the technical entry risk.
CounterThe large 23-percent gap to the analyst target and the exceptional asymmetry ratio suggest the downtrend may already be overdone relative to fundamentals, in which case the technical setup resolves faster than the moving-average signals currently imply.
The put-to-call ratio stands at 2.33, a level well above normal that indicates the options market is heavily skewed toward downside protection — a signal that institutional participants are actively hedging against further price declines rather than positioning for a recovery.
→StableRisk breakdown
- Expectation
- The put/call ratio falls below 1.0 over the next two quarters as the downtrend reverses and the hedging overhang is unwound, removing a technical headwind to share-price recovery.
CounterElevated put/call ratios can represent contrarian bullish signals when sentiment reaches an extreme; the concentration of put activity may mark a sentiment trough from which the shares are close to recovering, rather than a sign of sustained institutional conviction in the downside.
Per-dimension breakdown
Quality
6.0/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 8.4 |
| ROA | 6.5 |
| Gross margin | 4.7 |
| Op margin | 7.6 |
| Net margin | 5.0 |
| Current ratio | 4.5 |
| FCF quality | 3.7 |
| Moat | 6.1 |
| Piotroski F | 7.8 |
- ▸Excellent ROE: 25%
- ▸Earnings quality RED FLAG: 47% FCF/NI
- ▸Strong Piotroski F-Score: 7/9
Growth
6.4/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 4.8 |
| EPS growth | 8.1 |
Momentum
6.5/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.5 |
| MACD | 2.5 |
| OBV | 10.0 |
| MA position | 4.0 |
| Volume | 10.0 |
| vol acceleration | 8.0 |
- ▸Volume accumulation (rising OBV)
- ▸Below 200-MA, MA slope -1.9%/30d — confirmed downtrend
- ▸Volume surge (2.0x avg) on up move
Sentiment
7.6/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 8.4 |
| Price target | 9.0 |
| erm sentiment | 4.8 |
- ▸Analyst upside: 37%
Insider
3.9/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 4.5 |
| insider conviction | 2.0 |
| holder change | 5.1 |
- ▸Modest insider selling — $3,029,860 (0.031% of mkt cap)
Peer rank
4.6/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 4.2 |
| quality rank | 8.0 |
| growth rank | 6.3 |
- ▸Best-in-class margins
Technical
5.0/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 4.5 |
| support resistance | 4.5 |
| 52w position | 6.0 |
Risk (lower is worse)
6.0/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 8.1 |
| days to cover | 7.3 |
| volatility | 4.4 |
| put call | 0.0 |
| implied vol | 6.1 |
| max pain risk | 7.0 |
| beta | 9.4 |
| debt equity | 6.0 |
- ▸Elevated put/call: 6.00
Catalyst
6.5/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 7.3 |
| dividend safety | 5.2 |
- ▸Perfect beat streak: 4Q
- ▸Dividend: 76.0%
How the verdict was assembled
Engine trigger
Maintain position. Not compelling to add more.
Engine technical detail
verdict_path:
L4:PATH_F_HOLDPassed (8)
- MOMENTUM:6.5>=5.5
- ASYMMETRY:3.0>=1.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:41d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (0)
none
Warning (1)
- DEATH_CROSS:momentum=6.5>=5.0 recovering
Reward-to-Risk
3.03
Upside
+19.5%
Downside
6.4%
Sizing output
AVOID
SetupRANGE_BOUND — RSI 48 mid-range, Bollinger mid-band
EdgeNO_EDGE — No clear edge identified
SuitabilityMODERATE — Balanced profile
Investment implication
None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: MOMENTUM:6.5>=5.5. Top dim: Value at 8.1; weakest: Insider at 3.9. No conviction either direction.
The strongest dimensions are Value at 8.1, Sentiment at 7.6, and Momentum at 6.5; the weakest are Insider at 3.9, Peer rank at 4.6, and Technical at 5.0. The V9 engine cleared all gates with 1 warning, producing an asymmetric reward-to-risk of 3.03 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1The company has beaten earnings estimates in each of the past four quarters, with an average positive surprise of approximately 9.6 percent — a track record that reflects consistent execution against guidance and suggests management is deliberately setting achievable targets.
Trip ifEPS surprise falls below 0% in any single reported quarter, breaking the beat streak.
- P2The shares sit 23 percent below the analyst consensus target at $122.23, and the risk/reward geometry clears the asymmetry bar required for a high-conviction setup — offering a materially favorable ratio of potential gain to potential loss at the current price of $99.36.
Trip ifShare price rises to $122.23 or above, signaling the full 23-percent upside to the analyst target has been captured.
- P3The share price is below its 200-day moving average, the 50-day has crossed below the 200-day, and the moving-average slope is declining at 1.4 percent per 30 days — a confirmed downtrend configuration that creates meaningful entry-timing risk regardless of the fundamental picture.
Trip ifShare price closes above $110 for 2 consecutive weeks, indicating the confirmed downtrend has reversed.
- P4The put-to-call ratio stands at 2.33, a level well above normal that indicates the options market is heavily skewed toward downside protection — a signal that institutional participants are actively hedging against further price declines rather than positioning for a recovery.
Trip ifPut/call ratio falls below 1.0 from the current 2.33, signaling the bearish options positioning has been unwound.